Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Axsome Therapeutics (AXSM) has a market cap of $5.06 billion USD. According to our data, Axsome Therapeutics is ranked No.2529 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $5.06 B |
23.48%
|
| Dec 31, 2024 | $4.10 B |
6.31%
|
| Dec 29, 2023 | $3.86 B |
3.19%
|
| Dec 30, 2022 | $3.74 B |
104.16%
|
| Dec 31, 2021 | $1.83 B |
-53.63%
|
| Dec 31, 2020 | $3.95 B |
-21.18%
|
| Dec 31, 2019 | $5.01 B |
3,565.25%
|
| Dec 31, 2018 | $0.14 B |
-49.64%
|
| Dec 29, 2017 | $0.27 B |
-17.04%
|
| Dec 30, 2016 | $0.33 B |
-27.18%
|
| Dec 31, 2015 | $0.45 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
| Market Cap | = | AXSM Stock Price | * | AXSM Shares Outstanding |
| = | $103.83 | * | 48.77 M | |
| = | $5.06 B |